PASS-assisted exploration of new therapeutic potential of natural products

Medicinal Chemistry Research (Impact Factor: 1.4). 04/2011; 20(9):1509-1514. DOI: 10.1007/s00044-010-9398-y


The use of drug substances derived from plants, fungi, bacteria, and marine organisms are “Mother Nature Gift” for diseases
of mankind. Many of these are discovered serendipitously and have a long tradition in medicine. Till date, the use of natural
products, their semisynthetic and synthetic derivatives have been mostly confined to their ethnic use. But it has been well
known that each substance has a wide spectrum of biological activities as evident from some new uses of many old drugs. PASS
(Prediction of Activity Spectra for Substances) has been employed as a strong potential tool to predict the biological activity
spectrum of synthetic substances for the discovery of new drugs. But the potential of PASS to predict the biological activity
spectra of natural products is still underestimated. The present study was therefore undertaken to investigate and correlate
the biological activity spectrum of the main phytoconstituent of some selected Indian medicinal plants with their reported
biological activities in order to evaluate the applicability of PASS. Further, the unexplored but PASS-predicted activities
having good activity score (Pa>0.7) for particular structure were listed as hidden potential of the plant.

KeywordsAyurveda–Biological activity spectrum–Herbal drugs–Natural products–PASS

Download full-text


Available from: Alexey Lagunin
  • Source
    • "For centuries, herbal preparations were used in the treatment of disease before the invention of antibiotics (Emeka et al., 2012). Herbal medicines are proficient in India since ancient times and now they are accredited globally as one of the treatment systems to mend infections (Goel et al., 2011). Plants are of rich interest among researchers for the past few decades because of their potent antimicrobial activities compared to standard antibiotics (Viswanathan et al., 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, we investigated the efficiency of phytochemical constituents from plants mentioned in the Siddha formulations such as Amirthavennai, Kungliavennai, and Mekavarna Kalimbu to inhibit Candidiasis. Enzymatic inhibition of lanosterol 14 α-demethylase and lumazine synthase by the phytochemicals identified from the plants was investigated through molecular docking studies. Grid-based ligand docking with energetics was performed on maestro suite of Schrödinger. Our results reveal that the binding pocket of the currently used drugs (fluconazole and clotrimazole) and the phytochemicals was same. Interestingly, the phytochemicals showed greater binding affinity than standard drugs. It is more likely that these lead compounds can pass through as drug candidates as they are going to be topical application for medication. As these formulations were used by proven efficacy in clinical practice in Siddha medicine system, our study could highlight the possible mechanism of action of phytochemicals present in Siddha formulations.
    Full-text · Article · May 2014 · Medicinal Chemistry Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: The design, development, and biological evaluation of the multitarget series of tetrahydroindolo-[2,3-c]quinolinones is based on the “old” drug ambocarb via the “deconvolution” approach and is reviewed for the potential treatment of neurodegenerative conditions.
    No preview · Article · Apr 2013 · Chemistry of Heterocyclic Compounds
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ficus religiosa L. (Moraceae) has been extensively used in traditional medicine for a wide range of ailments of the central nervous system, endocrine system, gastrointestinal tract, reproductive system, respiratory system and infectious disorders. To comprehend the fragmented information available on the botany, traditional uses, phytochemistry, pharmacology and toxicology of F. religiosa to explore its therapeutic potential and future research opportunities. All the available information on F. religiosa was collected via electronic search (using Pubmed, SciFinder, Scirus, Google Scholar, Agricola and Web of Science) and a library search. Ethnomedical uses of F. religiosa are recorded throughout South Asia, where it has been used for about 50 types of disorders. Phytochemical research had led to the isolation of phytosterols, amino acids, furanocoumarins, phenolic components, hydrocarbons, aliphatic alcohols, volatile components and few other classes of secondary metabolites from F. religiosa. Fresh plant materials, crude extracts and isolated components of F. religiosa showed a wide spectrum of in vitro and in vivo pharmacological activities like, antidiabetic, cognitive enhancer, wound healing, anticonvulsant, anti-inflammatory, analgesic, antimicrobial, antiviral, hypolipidemic, antioxidant, immunomodulatory, antiasthmatic, parasympathetic modulatory, esterogenic, antitumor, antiulcer, antianxiety, antihelmintic, endotheilin receptor antagonistic, apoptosis inducer and hypotensive. F. religiosa emerged as a good source of traditional medicine for the treatment of asthma, diabetes, diarrhea, epilepsy, gastric problems, inflammatory disorders, infectious disorders and sexual disorders. Although many of the experimental studies validated its traditional medicinal uses, but employed uncharacterized crude extracts. Thus, it is difficult to reproduce the results and pinpoint the bioactive metabolite. Hence, there is a need of phytochemical standardization and bioactivity-guided identification of bioactive metabolites. The results of few pharmacological studies and bioactive metabolites already reported in F. religiosa warrant detailed investigation for its potential against cancer, cardiovascular disorders, neuroinflammatory disorders, neuropsychiatric disorders, oxidative stress related disorders and parasitic infections. The outcome of these studies will further expand the existing therapeutic potential of F. religiosa and provide a convincing support to its future clinical use in modern medicine.
    No preview · Article · Feb 2011 · Journal of ethnopharmacology
Show more